HomeReleasesHedia Expands Digital Diabetes Management to Pedia...
Releases

Hedia Expands Digital Diabetes Management to Pediatric Patients

Hedia Expands Digital Diabetes Management to Pediatric Patients

Danish digital therapeutics firm Hedia has secured updated Medical Device Regulation certification, officially removing the 18-plus age restriction on its diabetes assistant software. This regulatory shift allows parents and caregivers to utilize the platform for pediatric patients, integrating specialized insulin regimens and expanded device connectivity into clinical workflows.

The updated certification enables Hedia to support younger patients through both its standalone application and integrated partner digital health platforms. By accommodating flexible insulin regimens tailored to pediatric needs, the company aims to improve glycemic control for children and teens managing type 1 diabetes. The software now provides seamless data synchronization across continuous glucose monitors, smart pens, and wearable devices, bridging the gap between home-based care and professional clinical oversight.

CEO Rasmus Kofoed emphasized that the move targets the specific precision required for pediatric care, linking clinics directly with families. Founded in 2016, the Copenhagen-based company plans to begin the rollout of these features shortly, focusing on streamlining daily therapy calculations and carbohydrate tracking for families and healthcare teams.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!